Gilead partners with the Global Fund to support Yeztugo access strategy on heels of FDA nod

9th July 2025 Uncategorised 0

The agreement is meant to help bolster affordable supply of the long-acting PrEP drug while Gilead’s voluntary licensing program with generics makers gets up and running.

More: Gilead partners with the Global Fund to support Yeztugo access strategy on heels of FDA nod
Source: fierce